Skip to main content

Natalie S. Grover

Natalie Grover, MD, is a UNC Lineberger Comprehensive Cancer Center member with a research interest in novel therapies for the treatment of lymphoma. Her focus is in cellular therapy, including innovative approaches to chimeric antigen receptor T-cell (CAR-T) therapy.

MD
Assistant Professor, Hematology
Clinical Director of Cellular Therapy Program
UNC-Chapel Hill
Clinical Research

Meet Natalie Grover

Area of Interest

My primary research interest is in novel therapies for the treatment of lymphoma. My particular focus is in cellular therapy including innovative approaches to chimeric antigen receptor T-cell (CAR-T) therapy, improving the efficacy of CAR-T cells, and management and prevention of unique toxicities associated with this treatment. My ultimate goal is to improve therapeutic options of lymphoma patients, while minimizing toxicities and maintaining their quality of life.

Awards and Honors

  • Oncology K12 Grant, 2018
  • ASCO/AACR Methods in Clinical Cancer Research Workshop, 2017
  • Cancer Outcomes Research Program Travel Award, UNC Lineberger Comprehensive Cancer Center, 2015
  • Department of Medicine Research Grant, University of Virginia, 2012
  • Crile Research Fellowship, Case Western Reserve University, 2008

Find publications on PubMed